Skip to Main Content

Paper Details

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
Nat Commun
38
2021
aneuploidy, human, melanocytes, melanoma, metastatic melanoma, patients, primary cutaneous melanomas, tumour, tumours, whole genome
Author NameAffiliation
Daniel L CameronWalter and Eliza Hall Institute of Medical Research
Daniel L CameronThe University of Melbourne
Rory WolfeSchool of Public Health and Preventive Medicine, Monash University
Phil F ChengUniversity of Zurich Hospital
Phil F ChengUniversity of Zurich Hospital
Reinhard DummerUniversity of Zurich Hospital
Reinhard DummerUniversity of Zurich Hospital
Nicholas K HaywardMelanoma Institute of Australia
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Nicholas K HaywardMelanoma Institute of Australia
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Richard A ScolyerMelanoma Institute of Australia
Richard A ScolyerSydney Medical School, The University of Sydney
Richard A ScolyerRoyal Prince Alfred Hospital
Raymond J ChoUniversity of California san francisco
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellThe University of Melbourne
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellThe University of Melbourne
Heather ThornePeter MacCallum Cancer Centre
Kathryn AlsopPeter MacCallum Cancer Centre
Kathryn AlsopPeter MacCallum Cancer Centre
Grant A McArthurPeter MacCallum Cancer Centre
Grant A McArthurThe University of Melbourne
Grant A McArthurPeter MacCallum Cancer Centre
Grant A McArthurThe University of Melbourne
Mitchell P LevesqueUniversity of Zurich Hospital
Mitchell P LevesqueUniversity of Zurich Hospital
Anthony T PapenfussWalter and Eliza Hall Institute of Medical Research
Anthony T PapenfussPeter MacCallum Cancer Centre
Anthony T PapenfussThe University of Melbourne
Anthony T PapenfussThe University of Melbourne
Anthony T PapenfussThe University of Melbourne
  • 1 - 33

Datasets

Release 1.2